Showing 1 - 20 results of 24 for search 'John Mascarenhas', query time: 0.05s
Refine Results
-
1
Next Generation Therapeutics for the Treatment of Myelofibrosis by Douglas Tremblay, John Mascarenhas
Published 2021-04-01
Article -
2
Myelofibrosis-Related Anemia: Current and Emerging Therapeutic Strategies by Leonard Naymagon, John Mascarenhas
Published 2017-12-01
Article -
3
A smoking gun? Clonal expansion in response to cigarette exposure by Daniel I. Nathan, John Mascarenhas
Published 2023-08-01
Article -
4
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor by Douglas Tremblay, Mikaela Dougherty, John Mascarenhas, Emily Jane Gallagher
Published 2023-06-01
Article -
5
Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety by Srdan Verstovsek, Ruben A. Mesa, Robert A. Livingston, Wilson Hu, John Mascarenhas
Published 2023-07-01
Article -
6
-
7
-
8
-
9
-
10
-
11
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression by Joseph Tripodi, Ronald Hoffman, Douglas Tremblay, Daiva Ahire, John Mascarenhas, Marina Kremyanskaya, Vesna Najfeld
Published 2024-04-01
Article -
12
P389: METHOTREXATE NEUROTOXICITY IN ADULT ALL by Hannah Levavi, Andre Khazak, Orrin Pail, Kyle Farina, Marina Kremyanskaya, John Mascarenhas, Michal Bar-Natan
Published 2023-08-01
Article -
13
-
14
P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN P... by Claire Harrison, John Mascarenhas, Daniela Cilloni, Richard Schlenk, Brian Jacoby, Robert J Slack, Vassilios Aslanis, Bhupinder Singh, Bertil Lindmark, Srdan Verstovsek, Raajit K Rampal
Published 2023-08-01
Article -
15
PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS W... by Andrew Kuykendall, Terrence Bradley, Rami S. Komrokji, Tymara Berry, Souria Dougherty, Laurie Sherman, Lixian Peng, Fei Huang, Ying Wan, Vivian Rodolf, Judy Ho, Shyamala Navada, John Mascarenhas
Published 2023-08-01
Article -
16
Interferons in the treatment of myeloproliferative neoplasms by Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek
Published 2024-02-01
Article -
17
P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS by Jan Bewersdorf, Helen Ajufo, Claire Harrison, Francesca Palandri, John Mascarenhas, Jeanne Palmer, Aaron T. Gerds, Jean-Jacques Kiladjian, Andrii Derkach, Karisse Roman-Torres, Sarah Buckley, Raajit K Rampal
Published 2023-08-01
Article -
18
P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS by Marina Kremyanskaya, Claire Harrison, Prithviraj Bose, Vikas Gupta, Raajit K Rampal, Jonathan Lambert, Moshe Talpaz, Alessandro Vannucchi, Andrew Kuykendall, Jean-Jacques Kiladjian, Srdan Verstovsek, Ruben Mesa, Gozde Colak, Sandra Klein, Carmelita Alvero, John Mascarenhas
Published 2023-08-01
Article -
19
PB2225: A RANDOMIZED OPEN-LABEL, PHASE 3 STUDY OF IMETELSTAT VS BEST AVAILABLE THERAPY IN INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED/REFRACTORY TO JAK INHIBITOR (IMPACTMF) by John Mascarenhas, Claire Harrison, Jean-Jacques Kiladjian, Katja Sockel, Alessandro Vannucchi, Tymara Berry, Denise Redding, Laurie Sherman, Souria Dougherty, Lixian Peng, Libo Sun, Fei Huang, Ying Wan, Vivian Rodolf, Judy Ho, Shyamala Navada, Rami S. Komrokji
Published 2023-08-01
Article -
20
European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera by Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L. Heaney, Andrew Kuykendall, Casey L. O’Connell, Jamile M. Shammo, Angela Fleischman, Ruben Mesa, Abdulraheem Yacoub, Ronald Hoffman, Erin Moshier, Nicole Zubizarreta, John Mascarenhas
Published 2022-06-01
Article